This project builds capabilities for therapeutic antibody development, fortifies early-phase clinical research infrastructure, advances biotech IP for the health and economic benefit of Canadians and...
AbCellera Biologics Inc.
9 records totalling $417,341,628.11 CAD, from official Government of Canada open data.
Embed this chart
Lobbying registry — possible match matched by name
An organization with this name appears in 22 federal lobbying registrations (1 currently active), between 2020 and 2026.
945748-366216-21 945748-366216-20 945748-366216-19
Matched automatically by organization name; a different organization with the same name is possible. The Registry of Lobbyists is the authoritative source. Lobbying is legal and regulated — this is context, not an allegation.
By department
| Innovation, Science and Economic Development Canada | $400,631,000 | 2 records |
| National Research Council Canada | $9,335,628 | 4 records |
| Western Economic Diversification Canada | $7,375,000 | 3 records |
Records
The project is in direct response to Canada's fight against COVID-19 and Canada's ability to respond to future pandemics. It will enable the rapid discovery of antibody therapies to treat and prevent...
Identify and develop antibody therapeutics for response and preparedness against COVID-19, and expand capacity for rapid development and delivery of antibody therapeutics.
Scale-up partnerships in therapeutic antibody discovery business
This project will develop, validate, and integrate new technologies to create a platform for the discovery of therapeutic antibodies against any target class, and with industry-leading speed, throughp...